IDL Biotech AB continues preparations to introduce its rapid test for bladder cancer, UBC Rapid, in the US. | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Latest News

September 2019

IDL Biotech AB continues preparations to introduce its rapid test for bladder cancer, UBC Rapid, in the US.

IDL Biotech has started the work on mapping the US market.

Read more here 

AroCell AB (publ) riktar offentligt uppköpserbjudande till aktieägarna i IDL Biotech AB (publ)

IDL Biotech AB uppmärksammar härmed att AroCell AB (publ) idag har lämnat ett uppköpserbjudande till aktieägarna i IDL att överlåta samtliga aktier till AroCell i utbyte mot 0,63 AroCell-aktier för varje aktie i IDL.

IDL Biotech is making progress in Africa

IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company delivers TUBEX® TF.

IDL Biotech

Skip this intro